Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report)’s share price was up 1.7% on Thursday . The company traded as high as $10.01 and last traded at $9.82. Approximately 35,063 shares changed hands during trading, a decline of 73% from the average daily volume of 131,466 shares. The stock had previously closed at $9.66.
Revolution Medicines Stock Performance
The firm’s 50-day simple moving average is $6.73 and its 200 day simple moving average is $3.83.
About Revolution Medicines
Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.
Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.
See Also
- Five stocks we like better than Revolution Medicines
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Revolution Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolution Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
